MA
WST icon

MCF Advisors’s West Pharmaceutical WST Stock Holding History

MCF Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
40
– – ﹤0.01% 967
2026
Q1 		$10K Hold
40
– – ﹤0.01% 966
2025
Q4 		$11K Buy
+40
New +$10.9K ﹤0.01% 806
2025
Q1 		– Sell
-3
Closed -$983 – 1027
2024
Q4 		$983 Hold
3
– – ﹤0.01% 914
2024
Q3 		$901 Buy
+3
New +$919 ﹤0.01% 914
2022
Q2 		– Sell
-3
Closed -$1K – 815
2022
Q1 		$1K Buy
+3
New +$1.17K ﹤0.01% 759
2021
Q4 		– Sell
-3
Closed -$1K – 701
2021
Q3 		$1K Buy
+3
New +$1.26K ﹤0.01% 744

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MCF Advisors's WST Position: Q2 2026 in Review

MCF Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 40 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

MCF Advisors first reported a position in WST in Q3 2021 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MCF Advisors held 40 shares of West Pharmaceutical worth $14.4K as of Q2 2026.
  • MCF Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #967 holding.
  • MCF Advisors first reported a position in West Pharmaceutical in Q3 2021 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.